Neopharm: brands it owns and its ownership tree
Neopharm (KRX: 092730) is a publicly listed company headquartered in Daejeon, South Korea that owns 5 consumer brands.[1]
Neopharm is a Daejeon skin care company founded in July 2000 that builds its products on MLE, its own formulation that mimics the lipid structure of healthy skin. It has been listed on KOSDAQ since January 2007. Its largest shareholder is the cosmetics group It's Hanbul, which with related parties held 41.34 per cent after buying more shares in October 2025. Sales in 2025 were 132.1 billion won, of which 25.9 billion won were exports.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- NeoPharm Co., Ltd. (also 주식회사 네오팜, 네오팜, NEOPHARM)
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇰🇷 Daejeon, South Korea
- Founded
- 2000
- Tickers
- KRX: 092730
- Last verified
- · 1 sources
Neopharm in numbers
- Neopharm owns 5 consumer brands tracked here across 1 top-level categories; the largest is personal care & beauty with 5 brands.[1]
Everything Neopharm owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Brand portfolio by category
Full portfolio, 5 brands, with sources → · Competitors by shared categories →
Recent changes to this record
Frequently asked questions
What brands does Neopharm own?
Neopharm owns 5 consumer brands tracked here, including REALBARRIER, ATOPALM, T'else, ZEROID and Derma:B.
Is Neopharm a South Korean company?
Yes. Neopharm is headquartered in Daejeon, South Korea and was founded in 2000.
Who owns Neopharm?
Neopharm is a publicly listed company owned by its shareholders; it trades as 092730 on the KRX.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] NeoPharm Co., Ltd. Business Report (사업보고서) for fiscal year 2025, filed with DART — NeoPharm Co., Ltd., Stock exchange filing, published 16 March 2026; retrieved 28 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.